ASO Author Reflections: Pathologic Complete Response of Extended CROSS Criteria Patients with Esophageal Cancer

por Wang, H. H., Plukker, J. Th. M., Hospers, G. A. P.
Publicado 2020

Prognostic Value of the Circumferential Resection Margin in Esophageal Cancer Patients After Neoadjuvant Chemoradiotherapy

por Hulshoff, J. B., Faiz, Z., Karrenbeld, A., Kats-Ugurlu, G., Burgerhof, J. G. M., Smit, J. K., Plukker, J. Th. M.
Publicado 2015

Extended Esophagectomy in Elderly Patients with Esophageal Cancer: Minor Effect of Age Alone in Determining the Postoperative Course and Survival

por Pultrum, B. B., Bosch, D. J., Nijsten, M. W. N., Rodgers, M. G. G., Groen, H., Slaets, J. P. J., Plukker, J. Th. M.
Publicado 2010

Effect of Extending the Original Eligibility Criteria for the CROSS Neoadjuvant Chemoradiotherapy on Toxicity and Survival in Esophageal Cancer

por de Heer, E. C., Hulshoff, J. B., Klerk, D., Burgerhof, J. G. M., de Groot, D. J. A., Plukker, J. Th. M., Hospers, G. A. P.
Publicado 2017

Detection of lymph node metastases with ultrasmall superparamagnetic iron oxide (USPIO)-enhanced magnetic resonance imaging in oesophageal cancer: a feasibility study

por Pultrum, B.B., van der Jagt, E.J., van Westreenen, H.L., van Dullemen, H.M., Kappert, P., Groen, H., Sietsma, J., Oudkerk, M., Plukker, J.Th.M., van Dam, G.M.
Publicado 2009

Value of EUS in Determining Curative Resectability in Reference to CT and FDG-PET: The Optimal Sequence in Preoperative Staging of Esophageal Cancer?

por Schreurs, L. M. A., Janssens, A. C. J. W., Groen, H., Fockens, P., van Dullemen, H. M., van Berge Henegouwen, M. I., Sloof, G. W., Pruim, J., van Lanschot, J. J. B., Steyerberg, E. W., Plukker, J. Th. M.
Publicado 2011